A client received idarucizumab for life-threatening bleeding… | MyMerci
More questions like thisTry ›
Adverse Effects/Contraindications/Interactions

A client received idarucizumab for life-threatening bleeding while taking dabigatran. 12 hours later, bleeding resumes and the diluted thrombin time is again prolonged. Which action is appropriate?

Explanation
Dabigatran concentrations can rebound after idarucizumab as drug redistributes, particularly with renal impairment. Recurrent bleeding with renewed coagulation prolongation requires urgent reassessment and may justify another 5-g dose.
Next question on this topicA client is admitted to the emergency department after ingesting an unknown amount of acet…From this question bankNCLEX 対策問題集KRW 79,000
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free

For study reference only. Always follow current clinical guidelines and your institution’s protocols.